PillRx only · Solution · Ophthalmic
Atropine Sulfate
Brands: Isopto Atropine · Atropine Sulfate
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$15.808
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
3
Active US suppliers
75%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
517
Rx · 2026 Q1
2.8K
Units dispensed
-0%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alcon Laboratories, Inc. | unknown | 2 | SUPPLYING |
| Bausch & Lomb Incorporated | unknown | 1 | SUPPLYING |
| Bausch & Lomb Americas Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 13, 2022RECALLRecall (Class II): Isopto Atropine (atropine sulfate ophthalmic solution) 1%, 5mL bottle, MFG: Alcon Surgical, NDC 0065-0303-55
cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.